The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...

A small new study suggests that time-restricted eating could help improve blood sugar control in some people, thus ...

Metformin, a diabetes drug, may slow aging in organs like the brain, kidneys, and lungs, as seen in a 3.5-year study.

Viking Therapeutics, Inc.'s stock surged 1,500% on the promising obesity drug VK-2735, with Phase 3 trials and potential for ...

Experts Amanda Kuit and Tim Noakes criticize the off-label use of Ozempic for weight loss, arguing it promotes a quick-fix ...

A critical review of the limitations posed by current preclinical animal models of Alzheimer's disease and of the oversimplistic assumptions proposed by the amyloid cascade hypothesis (ACH).

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

M etformin, a widely available generic drug used to treat type 2 diabetes, has recently garnered attention for its potential ...

A recent study published in JAMA Psychiatry has found that children who experience persistently high levels of inflammation ...

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...